scorecardresearch
Thursday, August 14, 2025
TopicPharmaceutical companies

Topic: Pharmaceutical companies

Indore firm linked to cough syrup deaths in Cameroon told to halt manufacture, govt tells Parliament

Naturcold, cough syrup supplied by Riemann Labs, was linked to deaths of 12 kids in Cameroon in March. This is 1st admission by govt of action taken in matter which was flagged by WHO.

Regulatory actions taken against 105 pharma companies, says health minister Mansukh Mandaviya

The action by national and state regulators comes after Indian-made cough syrups were linked to the deaths of dozens of children overseas.

WHO says 20 ‘contaminated’ drugs from Indian & Indonesian makers under scanner

WHO spokesperson says instances of contaminated drugs being found in 6 countries warranted Medical Product Alerts & that it takes reports of substandard medical products seriously.

Glenmark slashes price of HER2-positive breast cancer drug Trumab by 70%, making it cheapest in India

Breast cancer is one of the most commonly diagnosed cancers in India. Most existing Trastuzumab brands in Indian market are priced between Rs 40,000 and Rs 54,000 per 440 mg vial.

Govt cancels licence of 18 pharma companies in big crackdown on spurious medicines

The decision was taken by the drugs controller following inspections on 76 companies across 20 states, news agency ANI quoted official sources.

Pharma firms and diagnostics developers need to unite. They are catalysts for saving lives

Studies of drugs like remdesivir and hydroxychloroquine were underpowered and small, and the results were conflicting and, in many cases, inconclusive.

Molnupiravir helps in faster recovery of mild Covid patients, says Hetero after phase 3 trials

Hyderabad-based pharma company, Hetero, announced promising interim results of phase 3 trials and has approached DCGI for emergency use authorisation for the drug in India.

ZyCoV-D, the made-in-India Covid vaccine by Zydus Cadila, likely to hit markets in June

The Ahmedabad-based pharmaceutical firm plans to begin with manufacturing one crore doses a month. The vaccine is also being tested on adolescents.

Delhi HC asks govt to reply to PIL seeking firms to sell Remdesivir in domestic market

The plea claimed that there are more than 25 companies in India which manufacture the medicine, but only 6 to 8 are permitted to sell it in the domestic market.

Pharma industry warns of Covid drug shortages as raw materials prices surge 200%

Pharma firms say suspension of cargo from China has resulted hoarding, driving up prices of raw materials, seek govt intervention immediately.

On Camera

Asim Munir wants to be guardian of the Middle East. He’s fated to fail at home

Countering insurgency needs the Pakistan Army to demonstrate a political will that ties leaders at the centre with those in the borderlands. But it may not have the imagination.

Slashing GST on waste can unlock Rs 1.8 lakh crore, high tax hurting circular economy goals—CSE

Centre for Science and Environment in new report makes case for rationalising GST on waste material, saying most informal operators can’t afford high tax & it also hinders recycling.

India, US troops to undertake joint military exercise next month, first after Op Sindoor

21st edition of annual joint military exercise will be held from 1 to 16 September, aimed at sharing military tech, operational best practices & disaster relief coordination methods.

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.